Therapeutic modulation of inflammasome pathways

Inflammasomes are macromolecular complexes formed in response to pathogen‐associated molecular patterns (PAMPs) and danger‐associated molecular patterns (DAMPs) that drive maturation of the pro‐inflammatory cytokines interleukin (IL)‐1β and IL‐18, and cleave gasdermin D (GSDMD) for induction of pyro...

Full description

Saved in:
Bibliographic Details
Published in:Immunological reviews 2020-09, Vol.297 (1), p.123-138
Main Authors: Chauhan, Dhruv, Vande Walle, Lieselotte, Lamkanfi, Mohamed
Format: Article
Language:English
Subjects:
Activation
Cytokines
disease
GSDMD
IL‐1
immunotherapy
inflammasome
Inflammasomes
Inflammation
Interleukins
Invited Review
Invited Reviews
Macromolecules
Metabolic rate
Metabolism
Microorganisms
NLRP3
Pathogens
Pyroptosis
Transcription
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Inflammasomes are macromolecular complexes formed in response to pathogen‐associated molecular patterns (PAMPs) and danger‐associated molecular patterns (DAMPs) that drive maturation of the pro‐inflammatory cytokines interleukin (IL)‐1β and IL‐18, and cleave gasdermin D (GSDMD) for induction of pyroptosis. Inflammasomes are highly important in protecting the host from various microbial pathogens and sterile insults. Inflammasome pathways are strictly regulated at both transcriptional and post‐translational checkpoints. When these checkpoints are not properly imposed, undue inflammasome activation may promote inflammatory, metabolic and oncogenic processes that give rise to autoinflammatory, autoimmune, metabolic and malignant diseases. In addition to clinically approved IL‐1‐targeted biologics, upstream targeting of inflammasome pathways recently gained interest as a novel pharmacological strategy for selectively modulating inflammasome activation in pathological conditions.
ISSN:0105-2896
1600-065X
DOI:10.1111/imr.12908